Clinical Trials
Search our team at AdventHealth Research Institute
Showing 1 - 7 of 7 clinical trials matching your search
-
NCT06691984
Phase 3, Open-label, Multicenter, Randomized Study of Xaluritamig vs Cabazitaxel or Second Androgen Receptor-Directed Therapy in Subjects With Metastatic Castration-Resistant Prostate Cancer Previously Treated With Chemotherapy
This study is currently enrolling.Associated Conditions: GenitourinaryResearch Area: Clinical Cancer ResearchResearch Location: OrlandoThis study is being done to learn more about how safe and effective the investigational immunotherapy, xaluritamig is when compared to already approved standard treatments in people with prostate... -
NCT06551324
A Phase 3, Randomized, Open-Label Study of PF-06821497 in Combination with Enzalutamide Compared with Enzalutamide or Docetaxel in Participants with Metastatic Castration Resistant Prostate Cancer Previously Treated with Abiraterone Acetate (MEVPRO-1)
This study is currently enrolling.Associated Conditions: GenitourinaryResearch Area: Clinical Cancer ResearchResearch Location: OrlandoThe purpose of this study is to learn about the safety and effects of a compound called an EZH2 inhibitor (EZH2i) on your body when it is given in combination with a second drug, enzalutamide (an... -
rhPSMA-7.3(18F)-PET scan to detect prostate cancer in patients with early PSA recurrence.
This study is currently enrolling.Associated Conditions: GenitourinaryResearch Area: Clinical Cancer ResearchResearch Location: OrlandoThe research is being done at the Radiology Nuclear Medicine Department of AdventHealth Orlando and Celebration. Patients are instructed to drink water prior to administration of flotufolastat F-18 to... -
NCT05987241
MODERN: An Integrated Phase 2/3 and Phase 3 Trial of MRD-Based Optimization of ADjuvant ThErapy in URothelial CaNcer A032103
This study is currently enrolling.Associated Conditions: GenitourinaryResearch Area: Clinical Cancer ResearchResearch Location: OrlandoThis study is being done to answer the following question: After having your bladder surgically removed after being diagnosed with bladder cancer, can we better identify which patients need an... -
NCT06631521
Neoadjuvant Darolutamide and Relugolix combination preceding radical prostatectomy for high risk localized and locally advanced prostate cancer: a Phase I/Ib trial
This study is currently enrolling.Associated Conditions: GenitourinaryResearch Area: Clinical Cancer ResearchResearch Location: CelebrationThe primary study objective is to determine the safety and feasibility of a new combination of darolutamide and relugolix as neoadjuvant therapy preceding radical prostatectomy (RP) for high-risk... -
NCT06305767
A Phase 2, Randomized, Double-blind Study of Adjuvant V940 (mRNA-4157) + Pembrolizumab (MK-3475) vs. Placebo + Pembrolizumab for High-Risk Muscle-Invasive Urothelial Carcinoma (MIUC) Post-Radical Resection
This study is currently enrolling.Associated Conditions: GenitourinaryResearch Area: Clinical Cancer ResearchResearch Location: OrlandoTo compare V940 plus pembrolizumab to placebo plus pembrolizumab with respect to DFS. Hypothesis (H1): V940 plus pembrolizumab is superior to placebo plus pembrolizumab with respect to DFS as assessed... -
NCT04510597
PHASE III TRIAL OF IMMUNOTHERAPY-BASED DRUG COMBINATION THERAPY WITH OR WITHOUT CYTOREDUCTIVE NEPHRECTOMY FOR METASTATIC RENAL CELL CARCINOMA (PROBE TRIAL) (Study SWOG 1931)
This study is currently enrolling.Associated Conditions: GenitourinaryResearch Area: Clinical Cancer ResearchResearch Location: OrlandoPHASE III TRIAL OF IMMUNOTHERAPY-BASED DRUG COMBINATION THERAPY WITH OR WITHOUT CYTOREDUCTIVE NEPHRECTOMY FOR METASTATIC RENAL CELL CARCINOMA (PROBE TRIAL) (Study SWOG 1931)